Blog
RSS FeedPosted by Michael Wonder on 02 Jun 2020
Health Canada advises Canadians to help support the continued supply of medications
1 June 2020 - Health Canada recognizes that drug shortages can have a significant impact on patients and health care ...
Posted by Michael Wonder on 28 May 2020
Health Canada approves birth control arm implant Nexplanon
26 May 2020 - A popular birth control implant that has long been advocated for use in Canada has now ...
Posted by Michael Wonder on 27 May 2020
Rockwell Medical files new drug submission with Health Canada for marketing approval of Triferic AVNU
26 May 2020 - Rockwell Medical today announced the filing of a new drug submission with Health Canada for Triferic AVNU ...
Posted by Michael Wonder on 26 May 2020
Ofev (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases
25 May 2020 - Ofev slowed lung function decline in PF-ILD patients by 57% compared to placebo. ...
Posted by Michael Wonder on 21 May 2020
Mithra and Searchlight Pharma announce filing of new drug submission for Estelle in Canada
20 May 2020 - Searchlight Pharma's new drug submission for a novel combined oral contraceptive accepted for review by Health Canada. ...
Posted by Michael Wonder on 21 May 2020
Health Canada grants market authorisation to Rozlytrek (entrectinib) for ROS1-positive, locally advanced or metastatic non-small cell lung cancer patients, not previously treated with crizotinib
20 May 2020 - Data show responses in 73% of patients who were treated with Rozlytrek. ...
Posted by Michael Wonder on 19 May 2020
Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market
19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...
Posted by Michael Wonder on 13 May 2020
COVID-19 exposes drug supply gaps as 'made in Canada' solution proposed
10 May 2020 - For more than a decade, Canada has had a supply shortage of essential medication, an issue ...
Posted by Michael Wonder on 06 May 2020
AbbVie receives Health Canada approval for the combination of Venclexta (venetoclax) with obinutuzumab for patients with previously untreated chronic lymphocytic leukaemia
5 May 2020 - Venclexta (venetoclax) plus obinutuzumab is the first chemotherapy-free, fixed-duration combination regimen approved by Health Canada for patients ...
Posted by Michael Wonder on 30 Apr 2020
Teva Canada announces the launch of Ajovy for the preventive treatment of migraine in adults who have at least four migraine days per month
29 April 2020 - Ajovy is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive ...
Posted by Michael Wonder on 29 Apr 2020
Health Canada approves Rozlytrek (entrectinib) for NTRK gene fusion-positive solid tumours in locally advanced or metastatic patients
28 April 2020 - Data show more than half of trial patients across all 10 tumour types studied had responses to ...
Posted by Michael Wonder on 27 Apr 2020
Health Canada issues warning against use of hydroxychloroquine for COVID-19
26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...
Posted by Michael Wonder on 23 Apr 2020
Canada’s Apotex donates two million dosages of hydroxychloroquine to the Public Health Agency of Canada
21 April 2020 - Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile. ...
Posted by Michael Wonder on 21 Apr 2020
Alk announces Health Canada approval of Itulatek SLIT tablets for the treatment of tree pollen allergy
20 April 2020 - Over 20% of Canadians with allergies are impacted by tree pollen. ...
Posted by Michael Wonder on 20 Apr 2020
Crisis or not, Alberta must not do an end-run around Health Canada
20 April 2020 - On April 12, in response to a perceived delay in Health Canada’s approval of a Canadian-made ...